463 related articles for article (PubMed ID: 12959628)
1. Pharmacovigilance of herbal medicines : a UK perspective.
Barnes J
Drug Saf; 2003; 26(12):829-51. PubMed ID: 12959628
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of patient reporting of adverse drug reactions to the UK 'Yellow Card Scheme': literature review, descriptive and qualitative analyses, and questionnaire surveys.
Avery AJ; Anderson C; Bond CM; Fortnum H; Gifford A; Hannaford PC; Hazell L; Krska J; Lee AJ; McLernon DJ; Murphy E; Shakir S; Watson MC
Health Technol Assess; 2011 May; 15(20):1-234, iii-iv. PubMed ID: 21545758
[TBL] [Abstract][Full Text] [Related]
3. Pharmacovigilance of herbal medicines: Concerns and future prospects.
Choudhury A; Singh PA; Bajwa N; Dash S; Bisht P
J Ethnopharmacol; 2023 Jun; 309():116383. PubMed ID: 36918049
[TBL] [Abstract][Full Text] [Related]
4. The European Herbal Medicines Directive: could it have saved the lives of Romeo and Juliet?
Routledge PA
Drug Saf; 2008; 31(5):416-8. PubMed ID: 18422382
[TBL] [Abstract][Full Text] [Related]
5. Pharmacovigilance of herbal products in India.
Wal P; Wal A; Gupta S; Sharma G; Rai A
J Young Pharm; 2011 Jul; 3(3):256-8. PubMed ID: 21897669
[TBL] [Abstract][Full Text] [Related]
6. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
[TBL] [Abstract][Full Text] [Related]
7. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
[TBL] [Abstract][Full Text] [Related]
8. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
[TBL] [Abstract][Full Text] [Related]
9. A study on pharmacovigilance of herbal medicines in Lagos West Senatorial District, Nigeria.
Awodele O; Daniel A; Popoola TD; Salami EF
Int J Risk Saf Med; 2013; 25(4):205-17. PubMed ID: 24305559
[TBL] [Abstract][Full Text] [Related]
10. Pharmacovigilance of herbal medicines: the potential contributions of ethnobotanical and ethnopharmacological studies.
Rodrigues E; Barnes J
Drug Saf; 2013 Jan; 36(1):1-12. PubMed ID: 23315291
[TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance of herbal medicine.
Shaw D; Graeme L; Pierre D; Elizabeth W; Kelvin C
J Ethnopharmacol; 2012 Apr; 140(3):513-8. PubMed ID: 22342381
[TBL] [Abstract][Full Text] [Related]
12. How do patients contribute to signal detection? : A retrospective analysis of spontaneous reporting of adverse drug reactions in the UK's Yellow Card Scheme.
Hazell L; Cornelius V; Hannaford P; Shakir S; Avery AJ;
Drug Saf; 2013 Mar; 36(3):199-206. PubMed ID: 23444232
[TBL] [Abstract][Full Text] [Related]
13. [Pharmacovigilance off the beaten track: herbal surveillance or pharmacovigilance of medicinal plants].
Castot A; Djezzar S; Deleau N; Guillot B; Efthymiou ML
Therapie; 1997; 52(2):97-103. PubMed ID: 9231502
[TBL] [Abstract][Full Text] [Related]
14. Issues related to monitoring the safety of over-the-counter (OTC) medicines.
Bond C; Hannaford P
Drug Saf; 2003; 26(15):1065-74. PubMed ID: 14640771
[TBL] [Abstract][Full Text] [Related]
15. Different standards for reporting ADRs to herbal remedies and conventional OTC medicines: face-to-face interviews with 515 users of herbal remedies.
Barnes J; Mills SY; Abbot NC; Willoughby M; Ernst E
Br J Clin Pharmacol; 1998 May; 45(5):496-500. PubMed ID: 9643624
[TBL] [Abstract][Full Text] [Related]
16. Adverse drug reaction reporting in the UK: a retrospective observational comparison of yellow card reports submitted by patients and healthcare professionals.
McLernon DJ; Bond CM; Hannaford PC; Watson MC; Lee AJ; Hazell L; Avery A;
Drug Saf; 2010 Sep; 33(9):775-88. PubMed ID: 20701410
[TBL] [Abstract][Full Text] [Related]
17. Signal detection for Thai traditional medicine: examination of national pharmacovigilance data using reporting odds ratio and reported population attributable risk.
Wechwithan S; Suwankesawong W; Sornsrivichai V; McNeil EB; Jiraphongsa C; Chongsuvivatwong V
Regul Toxicol Pharmacol; 2014 Oct; 70(1):407-12. PubMed ID: 24945744
[TBL] [Abstract][Full Text] [Related]
18. New consumer guidance on herbal medicines.
Kerr C
Lancet Oncol; 2006 Sep; 7(9):714. PubMed ID: 16977733
[No Abstract] [Full Text] [Related]
19. Developing a pharmacovigilance system in the Philippines, a country of diverse culture and strong traditional medicine background.
Hartigan-Go K
Toxicology; 2002 Dec; 181-182():103-7. PubMed ID: 12505293
[TBL] [Abstract][Full Text] [Related]
20. Safety monitoring of herb-drug interactions: a component of pharmacovigilance.
Skalli S; Soulaymani Bencheikh R
Drug Saf; 2012 Oct; 35(10):785-91. PubMed ID: 22876741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
